Reply: ‘Behr syndrome’ with OPA1 compound heterozygote mutations

Reply: ‘Behr syndrome’ with OPA1 compound heterozygote mutations

Bibliographic Details
Main Authors:	Yu-Wai-Man, Patrick, Chinnery, Patrick F.
Format:	Online
Language:	English
Published:	Oxford University Press 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285186/

Similar Items

Reply: Early-onset Behr syndrome due to compound heterozygous mutations in OPA1
by: Yu-Wai-Man, Patrick, et al.
Published: (2014)

Reply: Sensorineural hearing loss in OPA1-linked disorders
by: Yu-Wai-Man, Patrick, et al.
Published: (2013)

Reply: Spastic paraplegia in ‘dominant optic atrophy plus’ phenotype due to OPA1 mutation
by: Yu-Wai-Man, Patrick, et al.
Published: (2011)

A multiple sclerosis‐like disorder in patients with OPA1 mutations
by: Yu‐Wai‐Man, Patrick, et al.
Published: (2016)

OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy
by: Yu-Wai-Man, Patrick, et al.
Published: (2011)

Behr’s Syndrome is Typically Associated with Disturbed Mitochondrial Translation and Mutations in the C12orf65 Gene
by: Pyle, Angela, et al.
Published: (2014)

Late presentation of cancer in compound heterozygote PMS2 mutation carrier
by: van Galen, Paulien P, et al.
Published: (2011)

Emil Behring's Medical Culture: From Disinfection to Serotherapy
by: SIMON, JONATHAN
Published: (2007)

BEHR ranks highest in satisfying customers with interior paint
Published: (2008)

Two novel compound heterozygous mutations in OPA3 in two siblings with OPA3-related 3-methylglutaconic aciduria
by: Lam, Christina, et al.
Published: (2014)

Syndromic parkinsonism and dementia associated with OPA 1 missense mutations
by: Carelli, Valerio, et al.
Published: (2015)

Reply: Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain
by: Pfeffer, Gerald, et al.
Published: (2014)

Compound heterozygote mutations in SPG7 in a family with adult-onset primary lateral sclerosis
by: Yang, Yi, et al.
Published: (2016)

Evaluation of CCK2 receptor binding ligands: the inheritance of Thomas Behr
by: Boerman, Otto C., et al.
Published: (2011)

The long and short of OPA1
by: Leslie, Mitch
Published: (2016)

Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation
by: Spiegel, Ronen, et al.
Published: (2016)

A Simple PCR–RFLP Method for Genetic Phase Determination in Compound Heterozygotes
by: Perry, Rodney T., et al.
Published: (2012)

Heterozygote Advantage for Fecundity
by: Gemmell, Neil J., et al.
Published: (2006)

Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1
by: LEE, JINHO, et al.
Published: (2016)

Diagnosis: Congenital Dyserythropoietic Anemia Type 2 Due to Compound Heterozygote Mutation in SEC23B Gene
by: Demircioğlu, Fatih, et al.
Published: (2015)

Bloody Diarrhea as a Presentation Manifestation of Familial Mediterranean Fever in a Patient with Compound Heterozygote Mutations of the MEFV Gene
by: Fallahi, Gholam Hossein, et al.
Published: (2013)

Compound heterozygote myocilin mutations in a pedigree with high prevalence of primary open-angle glaucoma
by: Young, Thomas K., et al.
Published: (2012)

Friedreich’s Ataxia: Clinical Presentation of a Compound Heterozygote Child with a Rare Nonsense Mutation and Comparison with Previously Published Cases
by: Vamshi K. Rao, et al.
Published: (2018-01-01)

Novel OPA1 mutation featuring spastic paraparesis and intestinal dysmotility
by: Kazamel, Mohamed, et al.
Published: (2014)

OPA1’s shortcut to mitochondrial fission
by: Short, Ben
Published: (2014)

First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation
by: Kamakari, Smaragda, et al.
Published: (2014)

Impact of heterozygote CFTR Mutations in COPD patients with Chronic Bronchitis
by: Raju, S Vamsee, et al.
Published: (2014)

Analysis of compound heterozygotes reveals that the mouse floxed Pax6tm1Ued allele produces abnormal eye phenotypes
by: Dorà, Natalie J., et al.
Published: (2016)

Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations
by: Pfeffer, Gerald, et al.
Published: (2013)

Mudd’s disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes
by: Chien, Yin-Hsiu, et al.
Published: (2015)

Reply: Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain
by: Pfeffer, Gerald, et al.
Published: (2014)

The Effect of OPA1 on Mitochondrial Ca2+ Signaling
by: Fülöp, László, et al.
Published: (2011)

Disorders of the Optic Nerve in Mitochondrial Cytopathies: New Ideas on Pathogenesis and Therapeutic Targets
by: Sitarz, Kamil S., et al.
Published: (2012)

Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategies
by: Yu-Wai-Man, Patrick, et al.
Published: (2011)

Heterozygote manifestations in X-chromosomal ectodermal dysplasia
by: Gal, Andreas
Published: (2012)

Oxidative stress and antioxidant status in beta-thalassemia heterozygotes
by: Ondei, Luciana de Souza, et al.
Published: (2013)

OR2-002 – The risk of FMF in MEFV heterozygotes
by: Jéru, I, et al.
Published: (2013)

Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid
by: Lara, Beatriz, et al.
Published: (2014)

Construction of Opa-Positive and Opa-Negative Strains of Neisseria meningitidis to Evaluate a Novel Meningococcal Vaccine
by: Sadarangani, Manish, et al.
Published: (2012)

Correction: Construction of Opa-Positive and Opa-Negative Strains of Neisseria meningitidis to Evaluate a Novel Meningococcal Vaccine
by: Sadarangani, Manish, et al.
Published: (2013)